Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01730872 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
A Phase 4 study, sponsored by ORA.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01730872 is a Phase 4 study that has completed, run by ORA. The registered enrollment target is 16 participants.
The verdict
NCT01730872, a Phase 4 study, has completed, sponsored by ORA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of the modified Conjunctival Allergen Challenge (CAC) and observe how the produced allergic inflammation reacts to treatment with a proven ocular anti-inflammatory medication, Prednisolone, assessed by the following measures: Chronic Allergic Inflammation assessed using confocal microscopy Ocular itching Conjunctival redness
Interventions
- DRUG Prednisolone Sodium Phosphate Ophthalmic Solution 1%
- DRUG Tears Naturale II Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01730872
The ClinicalTrials.gov registry entry for NCT01730872 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ORA, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisolone Sodium Phosphate Ophthalmic Solution 1% is the first listed.
NCT01730872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01730872 about?
NCT01730872 is a clinical study titled "Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model". The purpose of this study is to evaluate the effectiveness of the modified Conjunctival Allergen Challenge (CAC) and observe how the produced allergic inflammation reacts to treatment with a proven ocular anti-inflammatory medication, Prednisolone, assessed by the following measures: Chronic Aller...
What is the current status of trial NCT01730872?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2012-11. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01730872?
The interventions under investigation include: Prednisolone Sodium Phosphate Ophthalmic Solution 1% (DRUG), Tears Naturale II Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT01730872?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.